News
4 Oct 2021
Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility in Carlsbad, California
Responding to critical market capacity constraints, Thermo Fisher announces the official opening of new 67,000 sqft cGMP plasmid DNA manufacturing facility in Carlsbad, CA. This site expands clinical and commercial capabilities for cGMP plasmid DNA used as a critical raw material to develop and manufacture cell and gene-based therapies in addition to capabilities to produce large-scale plasmid DNA as a primary drug substance for DNA therapies.
Accelerate development of plasmid-based medicines and vaccines
Mentioned Companies
Thermo Fisher Scientific Inc.
Related News
-
Sponsored Content PharmaNutra announces new technology to combat iron deficiency
This oral solution allows for high iron absorption while minimising digestive issues -
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&A
Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am... -
Sponsored Content Rise in home-based healthcare shaping pharma packaging and drug delivery
The pharma packaging and drug delivery industry has long been synonymous with rapid innovation. As medicine advances and patient needs change, so too should drug packaging and devices. This has been particularly evident during the pandem... -
Sponsored Content Biologics earmarked as opportunity in pharma packaging and drug delivery
The pharma packaging and drug delivery industry has gone through many evolutions, most notably to meet the challenges posed by the COVID-19 pandemic over the last two years. Disruptions to global supply chains posed a major issue, combined with a sharp... -
Sponsored Content Sustainability and digital adoption among trends shaping pharma packaging and drug delivery
The pharma packaging and drug device industry is constantly evolving to optimise drug delivery, keep up with medical advances and ensure regulatory compliance. Trends like sustainability, cost-efficiency and digitisation continue to shape the sector, a... -
Sponsored Content Croda: Solutions for Your High Value Drug Products
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various ch... -
Sponsored Content Audits in the time of COVID-19 – Implications for a CMO
Travel restrictions imposed by the pandemic have limited the ability of pharmaceutical companies and health authority personnel to travel and conduct in-person inspections of contract manufacturing organizations (CMOs). Due to t... -
Sponsored Content Avanti & Croda-Denmark: Advancing Vaccine Adjuvant Research
Adjuvants. You’ve seen them on our website. You’ve seen them featured in our blog articles. Now we want to show you how Avanti’ & Croda-Denmark can enhance your vaccine adjuvant research! Keep reading to learn more!
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance